Stability Assessment Of Biologics During Early Development Workflows
Source: NanoTemper Technologies, Inc.

During early development of biologics, there are a large number of attributes researchers evaluate, but some of the most common center around stability – asking if a biologic is well-folded, active, and pure in its buffer, and whether it remains that way over time. Biophysical characterization measurements from nanoDSF, DLS, backreflection, and SLS are valuable for providing this information without using a lot of material.
Read more to see how each of these technologies are helpful for characterization of your candidates during biologic development prior to clinical trials.
access the Infographic!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online
X
Subscribe to Drug Discovery Online
NanoTemper Technologies, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more